Purchasing Considerations for Generics
September 2017 : Generic Drugs - Vol. 14 No. 9 - Page #1

In the third quarter of 2017, PP&P polled a random, nationwide sampling of health system pharmacy directors on the factors impacting their generic purchasing decisions. We asked about budgeting practices, the impact of pricing changes, supply reliability, adding biosimilars to formulary, and future spending projections, among other topics. A total of 371 responses were received, yielding a confidence interval of 4.92 (95% +/-4.92).

To read the full article, please log in or register.

Current Issue

Enter our Sweepstakes now for your chance to win the following prizes:

    Just answer the following quick question for your chance to win:

    To continue, you must either login or register: